Skip to main content

Table 4 Parameters, associated with achievement TCZ-off remission (Cox regression model)

From: Successful treatment with tocilizumab every 4 weeks of a low disease activity group who achieve a drug-free remission in patients with systemic-onset juvenile idiopathic arthritis

Risk factor Hazard ratio P-value §
Fever before TCZ initiation: no (reference category: yes) 3.15 0.02
MAS after TCZ initiation: no (reference category: yes) 30.5 0.015
Lymphadenopathy before TCZ initiation: no (reference category: yes) 2.6 0.04
Coagulopathy before TCZ initiation: no (reference category: yes) 30.5 0.015
CNS dysfunction before TCZ initiation: no (reference category: yes) 3.8 0.04
Low diseases activity: TCZ Q2W (reference category: Q4W) 0.22 0.004
  1. Event of interest: achievement TCZ-off remission. Complete data were available for 33 patients.
  2. §P values refer to the Wald’s chi2-test.